Members of Lupus Ontario established a Fellowship in memory of their colleague, the late Geoff Carr. The annual Fellowship is designed to provide advanced training to a rheumatologist specializing in lupus at an […]
Updated Biosimilar Fact Sheet Reflecting ODB Formulary Changes Effective August 2021
An updated version of the biosimilar fact sheet is available here: August 24 Biosimilar-Fact-Sheet […]
Verified Virtual Visit Solutions for Providers
To assist health service providers in the selection of virtual care solutions appropriate for clinical use, Ontario Health has established a provincial standard (The Standard) and launched a verification process for virtual care […]
JointHealth™ express – ACE National Survey on Arthritis Self-Advocacy (For Patients)
Arthritis Consumer Experts (ACE) is conducting a National Survey on Self-Advocacy. Please support this initiative by sharing with your patients. The link below offers more information, including the survey link: Self Advocacy Survey […]
Updated Biosimilar Fact Sheet
June 24 Biosimilar-Fact-Sheet […]
Updated Recommendations From the Vaccine Clinical Advisory Group
The Vaccine Clinical Advisory Group has published updated Recommendations on Exceptions to Extended Dose Intervals for COVID-19 vaccines. Please note that this is not yet government policy. To review the entire report, click […]
New Feature on SADIE: The Exceptional Access Program Digital Assistant – Now With Delegates!
The Ministry of Health continues to modernize the Exceptional Access Program (EAP) and transition away from fax-based processes by December 31, 2021. As the next major step forward, you can now assign delegates in SADIE who can create and […]
Attestation Forms to Confirm Vaccine Eligibility Not Required
The Ministry of Health has communicated to all 34 public health units that attestation forms and doctors’ notes are not required to confirm vaccine eligibility. This is in response to the OMA advocating to the government that […]
Information for Switching Actemra IV Patients to Subcutaneous
The ORA has prepared an important communication piece to explain this matter. You may view it here: Important information for switching Actemra IV patients to subcutaneous […]
New MOH Email Information Service
New MOH Email Information Service The Ontario Claims Services Branch has introduced subscription services for physicians and other health-care providers to receive email communications starting this month. This is a new resource to […]
